We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. OK, I agree | Cookies Policy



Aprotecol® launched in Spain

We are pleased to announce the launch of APROTECOL®, our new product for reducing the symptoms of infant colic, in its first market, Spain. The product is distributed by FERRER. Aprotecol® is a Class IIa CE marked medical device intended for the treatment of meteorism, aerophagy and flatulent colic in infants and children. Aprotecol® has been available as drops for oral administration in Spanish pharmacies from the beginning of September.

Read more

Congresses: Noventure participates at NeuroGASTRO 2017, Cork, Ireland, with an innovative approach to IBS

Noventure, as part of its continued commitment to Gastroenterology, participated at the recent NeuroGASTRO 2017 meeting, which brought together leading experts and young investigators in neurogastroenterology, digestive motility and functional gastrointestinal diseases from Europe and from all around the world. The new product Gelsectan® was depicted at the Noventure´s stand as a teaser campaign, under the motto “Mucoprotection”.

Read more

Let's meet in..

2019, Nov 05

CPhI 2019

Read more

2019, Nov 25

euroPLX 71

Read more

2019, Nov 28

PharmaVenue November 2019

Read more